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Abstract
Background: The role of asthma controller medication adherence and the level of asthma control in children is poorly
defined.
Aims: To assess the association between asthma controller medication adherence and asthma control in children using
routinely acquired prescribing data.
Methods: A retrospective observational study of children aged 0–18 years prescribed inhaled corticosteroids only (ICS),
leukotriene receptors antagonists (LTRA), or long-acting b2 agonists (LABA) and ICS prescribed as separate or combined
inhalers, between 01/09/2001 and 31/08/2006, registered with primary care practices contributing to the Practice Team
Information database. The medication possession ratio (MPR) was calculated and associations with asthma control explored.
Poor asthma control was defined as the issue of prescriptions for $1 course of oral corticosteroids (OCS) and/or $6 short-
acting b2 agonists (SABA) canisters annually.
Results: A total of 3172 children prescribed asthma controller medication were identified. Of these, 15–39% (depending on
controller medication) demonstrated adequate MPR. Adequate MPR was associated with male gender, good socio-
economic status, and oral LTRA therapy. Adequate MPR was more likely to be associated with increased use of rescue
medication. However logistic regression only identified a significant relationship for ICS only (odds ratio [OR], 1.89; 95%
confidence interval [CI], 1.35–2.48; p,0.001), LTRA (OR, 2.11; 95% CI, 1.27–3.48; p = 0.004) and LABA/ICS (OR, 2.85; 95% CI,
1.62–5.02; p,0.001).
Conclusion: Poor adherence was observed for all asthma controller medications, although was significantly better for oral
LRTA. In this study adequate adherence was not associated with the use of less rescue medication, suggesting that
adherence is a complex issue.
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Introduction
Asthma medications are among the most commonly prescribed
medicines for children in the community [1], however despite the
availability and proven efficacy of such medications, asthma
remains a major cause of morbidity. Scottish health survey data for
2010 confirms that despite an overall decrease in the annual
incidence in children of both wheeze and asthma, they remain
common childhood complaints with 22% and 13% of children
aged 0–15 having a history of wheeze, and a medical diagnosis of
asthma respectively [2]. Asthma management in children can be
challenging for a number of reasons, including limited outcome
data, inappropriate prescribing and poor adherence with pre-
scribed therapy [3–7].
It is generally recognized that adherence with prescribed
medications in children is poor, with less than 50% using their
asthma controller medication as prescribed [8–9], which in turn is
associated with poor asthma control [5–7]. There are, however,
few studies which have investigated the relationship between
asthma control and adherence in children [5–7,10–12].
The aims of this study were to assess the association between the
levels of adherence with asthma controller medication and asthma
control using routinely collected primary care prescribing data.
Methods
Study Population
This observational retrospective study used data from the
Practice Team Information (PTI) database [13]. Children who
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were issued a new prescription for one of the four following classes
of asthma controller medications were identified; inhaled cortico-
steroids only (ICS), leukotriene receptors antagonists (LTRA),
long-acting b2 agonists (LABA) and ICS prescribed concurrently
as separate inhalers (LABA+ICS) or as a fixed-dose combination
(LABA/ICS), between 01/09/2001 and 31/08/2006. The date of
the first prescription was regarded as the index date. To be
included in the study, a child was required to be registered in the
database for at least a year before and a year after the index
prescription date.
Measures of Adherence
Adherence with asthma controller medication was assessed
using the medication possession ratio (MPR), a methodology
which is commonly used in adherence research [7–8,14–18].
The MPR is a measure of medication availability and is
calculated as the total number of days’ supply of medication
prescribed divided by the total number of days in the follow up
period, multiplied by 100, and expressed as a percentage:
MPR~
Daysofdrugsupply
Followupperiod
X100:
where days of drug supply equals the number of days a
prescription should last based on the dosing instructions of the
prescriber (Days of drug supply = number of doses in a
prescription divided by the dosing frequency). The follow up
period is the interval between first and last prescription for that
patient. Since at least two prescriptions were required to calculate
the follow-up period, only children with two or more consecutive
prescriptions were included in the study. For children prescribed
LABA+ICS, days of ICS drug supply were calculated.
Ideally, a 200 dose inhaler, prescribed as one puff twice daily,
should last 100 days and a repeat prescription requested after
approximately 100 days, i.e. MPR=100%. Requesting a repeat
prescription after or before 100 days would result in undersupply
or oversupply. In the present study, adequate MPR was defined as
drug supply covering 80–120% of the duration of prescribed
treatment, a range that has been used previously to evaluate both
low adherence and stockpiling of therapy [15].
Outcome Measures
The level of asthma control was assessed by identifying both the
number of short-acting b2 agonist (SABA) inhalers and/or courses
of oral corticosteroids (OCS) prescribed annually during the study
period. Prescription of more than 6 canisters of SABA and/or at
least one OCS rescue course annually was used as an indication of
poor control [5–6,13,16].
Statistical Analyses
Descriptive statistics were used to determine baseline population
characteristics. MPR was dichotomised as either adequate (MPR
between 80–120% inclusive) or inadequate (MPR outwith the 80–
120% range). MPR association with age (grouped into 0–4, 5–11
and .11 years age bands), gender, socio-economic status (Scottish
Index of Multiple Deprivation (SCSIMD) dichotomized into low,
0–5 and high, 6–10) and post index prescribing of SABA (,6
canisters vs. $6) and OCS (none vs. $1) was assessed. To confirm
relationships between adequate MPR and asthma control,
associations were explored using the chi-square test followed by
multivariate logistic regression analysis adjusting for age, gender,
socio-economic status and prescribing of other asthma medica-
tions. All analyses were performed using SPSS (SPSS for Windows
V.17.0). Where appropriate a two sided t test was used and a p
value of ,0.05 was considered significant. Adjusted odds ratios
(OR) and 95% confidence intervals (CI) were reported for
multivariate logistic regression results.
Results
We identified 53,736 prescriptions for the controller medica-
tions of interest issued during the study period. The MPR could be
calculated for 92% of these prescriptions. The final cohort
included 3172 children of whom 2297 were prescribed ICS alone,
394 LTRA, 481 fixed dose combination LABA/ICS, and 219
concurrent LABA+ICS (Table 1).
Adherence Rates
For the medications of interest, the MPR was poor, ranging
from close to 0 to over 200% (Figure 1). Depending on the
controller medication, between 15–39% of children had an
adequate MPR (defined as MPR between 80–120%). The
proportion of children with an adequate MPR was significantly
greater for LTRA when compared with other controller medica-
tions (39%, p,0.05). Oversupply (MPR.120%) was observed in
9–21% of the study group and was greatest for those prescribed
concurrent LABA+ICS (Table 2, Figure 1). Under supply
(MPR,80%) was more common than oversupply and was
observed in 51–69% of the study population. Undersupply was
significantly greater in children prescribed ICS only when
compared with other controller medication (p,0.001, Table 2,
Figure 1).
Factors Influencing Adherence Rates
Adequate MPR (80–120%) was higher in boys than girls, better
in children with higher SCSIMD scores, and significantly higher
for children prescribed oral LTRA when compared to other
controller medications (Tables 1,2). Adequate MPR was also
significantly greater in younger children aged,5 managed on ICS
Table 1. Baseline characteristics of children prescribed
different asthma controller medications.
Characteristic
ICS only
N=2297
N %
LTRA
N=394
N %
LABA/ICS
N=481
N %
LABA+ICS
N=219
N %
Mean age, years 6 6 9 8
Male (%) 1357 (59.0) 227 (57.6) 256 (53.2) 126 (57.5)
scsimd10 (%)
Low 1048 (55.7) 166 (42.1) 251 (52.1) 75 (34.2)
High 1249 (44.3) 228 (57.9) 230 (47.9) 144 (65.8)
Pre-index SABA
(%)
,6 canisters/year 1311 (95.7) 269 (74.9) 342 (77.5) 136 (75.9)
6–9 canisters/year 41 (3.1) 58 (16.2) 63 (14.4) 26 (14.7)
9 canisters/year 17 (1.2) 32 (8.9) 36 (8.1) 17 (9.4)
Pre-index OCS (%) 212 (9.2) 116 (29.4) 111 (23.0) 71 (32.4)
ICS = Inhaled corticosteroid; LTRA = leukotriene receptors antagonists; LABA/ICS =
fixed dose long-acting b2 -agonist and inhaled corticosteroids combination;
LABA+ICS = concurrent long-acting b2 -agonist and inhaled corticosteroids
separate inhaler; SCSIMD = Scottish Index of Multiple Deprivation; SABA= Short-
acting b2–agonist; OCS = Oral corticosteroids.
doi:10.1371/journal.pone.0039130.t001
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as their only controller medication (p,0.001) when compared to
older children and adolescents prescribed the same regimen
(Table 3).
Medication Possession Ratio vs Asthma Control
Significantly more children with adequate MPR were pre-
scribed .6 SABA canisters per year when compared to those with
an inadequate MPR for all study medications. However,
multivariate logistic regression confirmed this association for ICS
only, LTRA and LABA/ICS (Tables 3,4). More children with
adequate MPR were also prescribed OCS in the post index year,
when compared to those with inadequate MPR, this difference
failed to reach statistical significance (Table 5). Multivariate
logistic regression analyses demonstrated a similar relationship
between adequate MPR and OCS.
Because the proportion of children oversupplied medication was
relatively small, further analysis of data according to asthma
medication supply status, under or over supply, made no
difference to any of the observed outcomes.
Discussion
Summary of Main Findings
The findings from this study confirm and extend the results of
previous studies which have reported poor adherence with asthma
controller medications amongst children [7–8,14–18]. However
the relationship between low level asthma medication adherence
and disease control appears complex with evidence to suggest that
adequate MPR is associated with greater use of rescue medication.
Strengths and Limitations of the Study
This study examined adherence levels in a large paediatric
population in a ‘‘real world’’ primary care setting. The assessment
of adherence with asthma medication is important and permits
identification of patients requiring further intervention, and the
evaluation of clinical outcomes associated with poor adherence. In
addition, using this methodology adherence in a large population
can be assessed without influencing patient behaviour and
avoiding reporting and/or interviewer bias. Nevertheless, this
study has several limitations: prescribing databases cannot confirm
whether the medications were actually used. However, previous
studies have reported that adherence rates, measured using
healthcare databases, demonstrate high concordance with rates
assessed by objective and accurate methods such as weighing
Figure 1. Box plot for the distribution of Medication Possession Ratio of prescribed asthma controller medications. Whiskers
represent the extreme values, and boxes represent the 75th quartile, median, and 25th quartile. Outliers were excluded from the analysis. MPR=
Medication possession ratio; ICS = Inhaled corticosteroid; LTRA= leukotriene receptors antagonists; LABA/ICS = fixed dose long-acting b2-agonist and
inhaled corticosteroids combination; LABA+ICS = concurrent long-acting b2-agonist and inhaled corticosteroids separate inhaler.
doi:10.1371/journal.pone.0039130.g001
Table 2. Medication Possession Ratio for different asthma
controller medications.
Variable ICS only LTRA LABA/ICS LABA+ICS
Adequate MPR (%) 356 (15) 156 (39) 123 (25) 62 (28)
Under supply (%) 1574 (69) 204 (52) 260 (54) 113 (51)
Over supply (%) 367 (16) 34 (9) 98 (21) 44 (21)
Mean (SD) 70 (71) 75 (40) 93 (78) 91 (89)
Median (IQR) 51 (25–92) 70 (44–98) 88 (45–112) 82 (49–115)
Total 2297 394 481 219
ICS = Inhaled corticosteroid; LTRA = leukotriene receptors antagonists; LABA/ICS =
fixed dose long-acting b2 -agonist and inhaled corticosteroids combination;
LABA+ICS = concurrent long-acting b2 -agonist and inhaled corticosteroids
separate inhaler; MPR=Medication possession ratio; SD = Standard deviation;
IQR; Inter-quartile range.
doi:10.1371/journal.pone.0039130.t002
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inhalers, pill counting and/or electronic monitoring [19–20]. In
the present study prescribed medications were used as a proxy for
asthma diagnosis and severity assuming that medications were
collected by patients and used as prescribed. The use of
prescribing data may overestimate adherence in cases where the
treatment has been intended by the prescriber to be used
intermittently or seasonally. However, in this study, only children
on the BTS step 2 or higher asthma regimes were included in the
study population, therefore intermittent or seasonal use is unlikely
to be a significant issue.
Comparison with Existing Literature
As in previous reports, this study identified that the proportion
of children with adequate MPR for controller medications was
within the 11–28% reported by others [14–17] and that factors
associated with poor adherence include low socioeconomic status,
female gender and age greater than 12 years [19,21]. Similarly, in
this study the oral route was associated with significantly better
adherence when compared to inhalational therapies [18,22–24].
It has been previously reported that adherence rates tend to be
lowest in patients prescribed multiple medications, and simplifi-
cation of the treatment regimen by the use of combination inhalers
should improve adherence [17]. However in this study combina-
tion therapy (LABA/ICS) was not associated with improved
adherence and more children with adequate MPR were
prescribed separate LABA+ICS than combined LABA/ICS. A
similar finding was observed by Latry et al (2008), who reported
that adults with asthma adhered less well to LABA and ICS
treatment when it was delivered by a single inhaler than when it
was delivered concurrently via two separate devices [25]. This is a
surprising observation that seems to contradict the findings of
previous observational database studies [17,23,26–28]. One
possible explanation for this finding could be confounding by
asthma severity as children with more severe asthma may be
treated more aggressively and prescribed more LABA+ICS
resulting in higher drug supply and hence higher MPR. A further
possible explanation could be that patients on concurrent
LABA+ICS may overuse the LABA component of the prescrip-
tion, and then trigger a repeat prescription which is issued for both
LABA and ICS resulting in an apparently greater MPR in this
group. Finally, the apparent lower adherence associated with
combination inhalers might be attributed to what has been termed
‘‘depletion of susceptibles’’; that is patients identified by their GP
as poorly adherent with separate ICS + LABA therapy may be
prescribed a combined inhaler to improve their adherence,
resulting in an apparently greater rate of adherence in the
remaining subjects continuing to use ICS + LABA [25].
We expected to find a positive association between inadequate
adherence and poor asthma control reflected by increased
prescribing of rescue medication (OCS and SABA). However, in
this study, children with adequate MPR were more likely to be
prescribed OCS and/or six or more SABA canisters in the index
Table 3. Adequate MPR for asthma controller medications by deprivation index, age and gender.
Controller
treatment MPR 80–120%
SCSIMD Gender Age bands
0–5 6–10 Girls Boys 0–4 years 5–11 years .11 years
ICS only 153 (44.0) 195 (56.0) 142 (41) 206 (59) 170 (49)* 135 (39)* 43 (12)*
LTRA 69 (43.7) 89 (56.3) 69 (44) 87 (56) 72 (46) 69 (44) 15 (10)
LABA/ICS 67 (53.2) 59 (46.8) 54 (44) 69 (56) 17 (14) 77 (62) 29 (24)
LABA+ICS 30 (48.8) 32 (51.6) 23 (37) 39 (63)* 8 (13) 43 (69) 11 (18)
*P,0.001; ICS = Inhaled corticosteroid; LTRA = leukotriene receptors antagonists; LABA/ICS = fixed dose long-acting b2 -agonist and inhaled corticosteroids combination;
LABA+ICS = concurrent long-acting b2 -agonist and inhaled corticosteroids separate inhaler; SCSIMD = Scottish Index of Multiple Deprivation.
doi:10.1371/journal.pone.0039130.t003
Table 4. The relationship between reliever medication prescription in the post index year and the medication possession ratio.
Reliever medication ICS only LTRA LABA/ICS LABA+ICS
Adequate
MPR
Inadequate
MPR
Adequate
MPR
Inadequate
MPR
Adequate
MPR
Inadequate
MPR
Adequate
MPR
Inadequate
MPR
SABA
,6 canister/year 230 (76.9)* 1529 (85.4) 59 (62.8)** 235 (77.3) 44 (62.0)* 338 (82.8) 37 (57.8)** 123 (65.1)
6–9 canister/year 55(18.4)* 190 (10.6) 23 (24.5)** 44 (14.5) 16 (22.5)* 47 (11.5) 16 (25.0)** 45 (23.8)
.9 canister/year 14 (4.7)* 72 (4.0) 12 (12.8)** 25 (8.2) 11 (15.5)* 23 (5.6) 11 (17.2)** 21 (11.1)
OCS ($1 course/year ) 54 (18.1) 262 (14.6) 27 (28.7) 70 (23.0) 14 (19.7) 71 (17.4) 21 (32.8) 48 (25.4)
% of children with adequate vs inadequate MPR. e.g. x% of children with adequate MPR had an OCS prescription while xx% of those with inadequate MPR had an OCS
prescription.
*P,0.001;
**P,0.05.
SABA= Short-acting b2–agonist; OCS = Oral corticosteroids; ICS = Inhaled corticosteroid; LTRA = leukotriene receptors antagonists; LABA/ICS = fixed dose long-acting b2 -
agonist and inhaled corticosteroids combination; LABA+ICS = concurrent long-acting b2 -agonist and inhaled corticosteroids separate inhaler.
doi:10.1371/journal.pone.0039130.t004
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year. Similar observations have been reported by others
[13,21,24,29–30]. The reasons for this paradoxical finding are
not clear, but may indicate prescribing of an inadequate dose, or
poor inhalational technique leading to poor asthma control despite
optimum therapy [29,31]. Other reasons may include lack of
awareness of over prescribing of SABA and/or OCS in children
with adequate control due to multiple prescribers, automated and
telephone requests for repeat prescriptions [32] or that children
with poorly controlled asthma may have required more aggressive
treatment resulting in increased prescribing of asthma controllers
and hence higher MPR [33].
Implications for Future Research or Clinical Practice
The use of routinely acquired computerised prescribing data
permits a ‘‘real world’’ assessment of adherence, predictive factors
and possible outcomes. This study suggests that poor adherence to
asthma controller medication is common in children. Furthermore
poor asthma control, measured by requirement for rescue
medication, was evident even in children with an adequate MPR.
The association between level of asthma control and adherence
to controller medications does not appear to be a straightforward
issue as patients may reduce their prescribed controller medication
use without negative consequences [30] while others may continue
to have poor outcomes despite optimum treatment [34]. The
‘‘minimum accepted’’ level of adherence with asthma medications
to achieve control will remain a question.
Researchers should be aware of the challenges that can
compromise the validity of findings from such studies and of
various methodological approaches to address these possible
shortcomings. However, despite limitations, prescribing data
constitute an available, low cost method to assess adherence in
large populations and thereby to identify patients with low
adherence who may need further intervention to better manage
their disease.
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